Literature DB >> 8470575

MR appearance of multiple myeloma of the spine before and after treatment.

A Rahmouni1, M Divine, D Mathieu, M Golli, C Haioun, T Dao, M C Anglade, F Reyes, N Vasile.   

Abstract

OBJECTIVE: The aim of this study was to describe the changes in the MR appearance of painful lesions of the spine before and after treatment in 18 patients with multiple myeloma and to correlate these changes with the clinical response to treatment. SUBJECTS AND METHODS: Eighteen patients with multiple myeloma and tumor nodules in the spine had MR imaging of the same site in the spine before and after treatment. Unenhanced T1- and T2-weighted spin-echo images, dynamic ultrafast low-angle shot (turbo-FLASH) images before and after IV bolus injection of paramagnetic contrast material, and contrast-enhanced T1-weighted spin-echo images were obtained. Characteristic signal and contrast enhancement before and after treatment were compared and were correlated with clinical data and the results of immunochemical and pathologic tests.
RESULTS: Changes in signal intensity and enhancement of the lesions occurred after treatment in 14 of 18 patients. The characteristics of the lesions after treatment had three patterns: (1) rim enhancement or no enhancement of the lesions, (2) early enhancing lesions associated with other nonenhancing lesions or lesions with rim enhancement, and (3) no change from the enhancement pattern seen before treatment. In 13 of 18 patients, these patterns correlated well with the response to treatment. A discrepancy was observed in five patients.
CONCLUSION: The MR appearance of spinal myeloma is different before and after treatment. MR images, particularly contrast-enhanced images, may be helpful in monitoring the response to treatment of focal bone lesions of myeloma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8470575     DOI: 10.2214/ajr.160.5.8470575

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  11 in total

1.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2004-01-14       Impact factor: 3.909

2.  (11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment.

Authors:  Chieh Lin; Chi-Lai Ho; Shu-Hang Ng; Po-Nan Wang; Yenlin Huang; Yu-Chun Lin; Tzung-Chih Tang; Shu-Fan Tsai; Alain Rahmouni; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-16       Impact factor: 9.236

3.  Magnetic resonance imaging of bone marrow versus bone marrow biopsy in malignant lymphoma.

Authors:  M Ozgüroglu; G Esen Ersavasti; G Demir; H Aki; F Demirelli; K Kanberoglu; N Mandel; E Büyükünal; S Serdengeçti; B Berkarda
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 4.  Rheumatological manifestations of haematological diseases.

Authors:  S Menon; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

5.  Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma.

Authors:  M Horger; J Fritz; W M Thaiss; H Ditt; K Weisel; M Haap; Christopher Kloth
Journal:  Skeletal Radiol       Date:  2017-12-08       Impact factor: 2.199

Review 6.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

7.  Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.

Authors:  Natasa Gaspersic; Igor Sersa; Vladimir Jevtic; Matija Tomsic; Sonja Praprotnik
Journal:  Skeletal Radiol       Date:  2007-11-22       Impact factor: 2.199

8.  In vivo quantification of response to treatment in patients with multiple myeloma by 1H magnetic resonance spectroscopy of bone marrow.

Authors:  Albert Oriol; Daniel Valverde; Jaume Capellades; Miquel E Cabañas; Josep-Maria Ribera; Carles Arús
Journal:  MAGMA       Date:  2007-04-05       Impact factor: 2.310

Review 9.  MR imaging of therapy-induced changes of bone marrow.

Authors:  Heike E Daldrup-Link; Tobias Henning; Thomas M Link
Journal:  Eur Radiol       Date:  2006-09-21       Impact factor: 5.315

Review 10.  Whole body MRI and PET/CT in haematological malignancies.

Authors:  Chieh Lin; Alain Luciani; Emmanuel Itti; Corinne Haioun; Alain Rahmouni
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.